Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Q&A: Can inhaled vaccines mount comeback for one-time leader in China's Covid race?
3 years ago
China
Google health tech spinout Verily lays off staff amid exec departures
3 years ago
Calithera to shut down after failing to revive Takeda assets
3 years ago
Emergent to cut over 130 positions to kick off new year
3 years ago
Manufacturing
Six years later, SEC drops claims of accounting fraud against biotech exec
3 years ago
Law
An antibiotics biotech begins wind-down, lays off nearly all workers
3 years ago
R&D
The C-suite shuffle: Oncopeptides, Zymeworks replace execs to start 2023
3 years ago
Chris Viehbacher once again sets out to revamp R&D at a major biopharma. The last try led to his ouster
3 years ago
Bioregnum
R&D
Fulcrum CEO leaves for new opportunity, company starts search for replacement
3 years ago
California hearing-loss biotech fires all employees and outlines plan to liquidate
3 years ago
Taysha CEO steps down after patent fights with patient families, job cuts
3 years ago
Cell/Gene Tx
Paul McKenzie to take the reins of CSL as new CEO in March
3 years ago
Cell/Gene Tx
WIB22: Hear from our 2022 Women in Biopharma R&D honorees, and catch our panel on empowering women
3 years ago
Special
Bill Anderson to step down as Roche pharma chief by month's end
3 years ago
Pharma
WIB22: Amber Salzman had few options when her son was diagnosed with a rare genetic disease. So she created a better one
3 years ago
Special
WIB22: Leading NK cell researcher reflects on roots in Iran, the UK and Texas
3 years ago
Special
WIB22: Chasing after ever-evolving science takes a drug hunter across the pond
3 years ago
Special
WIB22: Suma Krishnan co-founded a company to develop a treatment for ‘the worst disease you’ve never heard of’
3 years ago
Special
WIB22: She reshaped migraine science and led key trials for new drugs, but Sheena Aurora isn’t done
3 years ago
Special
Sensei and Instil Bio let go large chunks of workforces, shift pipelines
3 years ago
As FDA door shuts on its PI3K, MEI Pharma throws in the towel, lays off staff
3 years ago
R&D
SQZ Biotech slashes headcount by 60% as founder/CEO hits exit — while Synlogic lays off 25%
3 years ago
R&D
In cash saving mode, Oncorus cuts trial, staff, lease, and pipeline
3 years ago
R&D
Updated: Catalent to cut about 600 jobs in Indiana, Maryland and Texas
3 years ago
Pharma
Manufacturing
First page
Previous page
34
35
36
37
38
39
40
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit